생체흡수성 관상동맥 스캐폴드(BCS) 시장 규모, 점유율 및 성장 분석 : 코어 매트릭스별, 제품 유형별, 약제 용출 기능별, 임상 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Bioresorbable Coronary Scaffolds Market size was valued at USD 1.05 Billion in 2024 and is poised to grow from USD 1.27 Billion in 2025 to USD 5.75 Billion by 2033, growing at a CAGR of 20.8% during the forecast period (2026-2033).

The global market for bioresorbable coronary scaffolds (BCS) is gaining traction due to their ability to temporarily support narrowed arteries before dissolving, eliminating the need for permanent metal implants. This innovation reduces long-term complications such as restenosis and late thrombosis, leading to a shift towards safer treatment options. Advances in BCS technology, including thinner struts and enhanced polymer chemistry, have increased clinical acceptance and attracted substantial investment in R&D. Moreover, the clinical benefits of restoring vascular freedom without permanent scaffolds are catalyzing reimbursements that favor BCS over traditional drug-eluting stents. As adoption grows, particularly among younger patients with complex lesions, manufacturers are encouraged to diversify product offerings and explore partnerships that enhance deployment precision, further driving market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioresorbable Coronary Scaffolds market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioresorbable Coronary Scaffolds Market Segments Analysis

Global bioresorbable coronary scaffolds market is segmented by material core matrix, product type, therapeutic drug elution, clinical application focus, end user and region. Based on material core matrix, the market is segmented into Polymer-Based Vascular Scaffolds and Metal-Based Vascular Scaffolds. Based on product type, the market is segmented into Synthetic Scaffolds and Biological Scaffolds. Based on therapeutic drug elution, the market is segmented into Sirolimus and its Analogues, Paclitaxel-Coated Scaffolds and Others. Based on clinical application focus, the market is segmented into Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD) and Others. Based on end user, the market is segmented into Hospitals & Cardiac Centers and Ambulatory Surgical Centers (ASCs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bioresorbable Coronary Scaffolds Market

The increasing preference for minimally invasive cardiac procedures is significantly enhancing the demand for bioresorbable coronary scaffolds. Healthcare professionals are increasingly opting for these devices to mitigate the long-term complications linked with permanent metal stents. Bioresorbable scaffolds offer temporary support, facilitating natural healing of the vessels, which resonates with patients' desires for less invasive treatment options. This trend is leading hospitals and catheterization laboratories to incorporate these advanced technologies into their practices, resulting in wider acceptance within the medical community. Moreover, the favorable safety profiles and clinical outcomes associated with these scaffolds are boosting physician confidence, further accelerating their adoption in various healthcare environments.

Restraints in the Global Bioresorbable Coronary Scaffolds Market

The global market for bioresorbable coronary scaffolds faces several significant barriers that hinder its growth. The manufacturing process necessitates advanced polymer processing and meticulous metal alloy fabrication, which relies on specialized equipment and strict quality assurance protocols. These factors elevate production costs and curtail economies of scale, resulting in a price-sensitive final product within cost-conscious healthcare environments. As a result, hospitals and insurers may be reluctant to embrace these devices, especially when more affordable conventional stents can achieve similar clinical outcomes. Furthermore, the requirement for extensive staff training on new deployment techniques adds to operational costs, creating additional reluctance for rapid adoption in budget-limited facilities.

Market Trends of the Global Bioresorbable Coronary Scaffolds Market

The Global Bioresorbable Coronary Scaffolds market is witnessing a significant trend towards personalized scaffold design, driven by clinicians' growing demand for solutions tailored to individual patient anatomy and lesion characteristics. This shift is propelling manufacturers to leverage advanced imaging and computational modeling techniques, which facilitate precise sizing, optimized radial strength, and controlled degradation rates. As hospitals increasingly invest in digital workflow platforms, suppliers that provide customizable design libraries and rapid prototyping are gaining a competitive edge. This movement towards personalized solutions is fostering broader acceptance and adoption of next-generation bioresorbable technologies, enhancing both procedural success and long-term patient outcomes globally.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Bioresorbable Coronary Scaffolds Market Size by Material Core Matrix & CAGR (2026-2033)

• Market Overview
• Polymer-Based Vascular Scaffolds
• Metal-Based Vascular Scaffolds

Global Bioresorbable Coronary Scaffolds Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Synthetic Scaffolds
• Biological Scaffolds

Global Bioresorbable Coronary Scaffolds Market Size by Therapeutic Drug Elution & CAGR (2026-2033)

• Market Overview
• Sirolimus and its Analogues
• Paclitaxel-Coated Scaffolds
• Others

Global Bioresorbable Coronary Scaffolds Market Size by Clinical Application Focus & CAGR (2026-2033)

• Market Overview
• Coronary Artery Disease (CAD)
• Peripheral Artery Disease (PAD)
• Others

Global Bioresorbable Coronary Scaffolds Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Cardiac Centers
• Ambulatory Surgical Centers (ASCs)

Global Bioresorbable Coronary Scaffolds Market Size & CAGR (2026-2033)

• North America (Material Core Matrix, Product Type, Therapeutic Drug Elution, Clinical Application Focus, End User)
  • US
  • Canada
• Europe (Material Core Matrix, Product Type, Therapeutic Drug Elution, Clinical Application Focus, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material Core Matrix, Product Type, Therapeutic Drug Elution, Clinical Application Focus, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material Core Matrix, Product Type, Therapeutic Drug Elution, Clinical Application Focus, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material Core Matrix, Product Type, Therapeutic Drug Elution, Clinical Application Focus, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• REVA Medical LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elixir Medical Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology Co Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoto Medical Planning Co Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amaranth Medical Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tepha Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QualiMed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arterial Remodeling Technologies SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Svelte Medical Systems Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascular Concepts
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino Medical Sciences Technology Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insyria
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations